Skip to main content
2024 Canadian Cardiovascular Congress Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Handout
Handout
Networking
Networking
On-Demand
On-Demand
Early Career Involvement
Early Career Involvement
Back

Nader A. Khalidi (he/him/his)

Professor of Medicine, Division Director Rheumatology, AbbVie Chair in Education in Rheumatology
McMaster University
McMaster University

Dr. Khalidi joined the McMaster University Department of Medicine in 2001. He graduated from the University of Manitoba and did his residency in Internal Medicine and Rheumatology at the University of Chicago at Illinois. He is currently Professor of Medicine, Division Director, Rheumatology at McMaster University and the AbbVie Chair in Education in Rheumatology.

He has been successfully involved in local, national and international vasculitis clinical research for the past 17 years. He has been involved as a Steering Committee Member and Co-Investigator of the North American Vasculitis Clinical Research Consortium (VCRC) and the Canadian Network of Investigators in Vasculitis (CanVasc). He is the PI of a local MRI-Giant Cell arteritis database that has now recruited over 600 patients and has had a major contribution to imaging of scalp arteries with Magnetic Resonance Imaging published in 2017 that has been supported in the European guidelines for use of imaging in large vessel vasculitis in clinical practice. He has been an investigator in the largest Vasculitis research project, DCVAS (Diagnostic and Classification in Vasculitis, Oxford) and was a top recruiter with over 150 patients as well as a contributor to the new diagnostic and classification criteria in development. He is to participate in ACR/EULAR response criteria in GCA that is currently under development.

Disclosure(s): AbbVie/Abbott: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Bristol-Myers Squibb(BMS): Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); GlaxoSmithKlein(GSK): Speaker/Honoraria (Terminated, June 15, 2023); NS Pharma: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Otsuka: Consultant/Advisory Board (Terminated, June 9, 2022); Roche: Speaker/Honoraria (Terminated, November 2, 2022); Sanofi: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated)

Presentation(s):